Article Sidebar

Published: 2026-04-01
Abstract Views: 0
DOI: https://doi.org/10.52163/yhc.v67iCD3.4739
Issue
Tập 67 Số CĐ3-NCKH
Section
Articles
How to Cite
An, N. T. B., & Hưng, N. L. . (2026). ASSOCIATED FACTORS OF TREATMENT COSTS OF INPATIENTS WITH TUBERCULOSIS AT BAC GIANG LUNG HOSPITAL IN 2024. Vietnam Journal of Community Medicine, 67(CD3). https://doi.org/10.52163/yhc.v67iCD3.4739

ASSOCIATED FACTORS OF TREATMENT COSTS OF INPATIENTS WITH TUBERCULOSIS AT BAC GIANG LUNG HOSPITAL IN 2024

Nguyen Thi Binh An1, Nguyen Luong Hung2
1 Thang Long University
2 Phuc Thuong Traditional Medicine Hospital

Main Article Content

Abstract

Objective: This study aims to describe the inpatient treatment costs and associated factors of inpatient cost of patients with Tuberculosis at the  Bac Giang Lung Hospital in 2024.


Subjects and Methods: A cross-sectional descriptive study using retrospective data from medical records and hospital invoices of inpatient in 2024. The total number of inpatients in this study was 405 patients. Descriptive analysis of mean, min, max and percentage was used to calculate the direct medical cost of TB patients. Linear regression was used to find associated factors of inpatients treatment costs


Results: The average total treatment cost per patient was VND 8.514.000. The associated factors included length stay, type of Tuberculosis and number of comorbidities. The average cost of inpatient care increases with longer hospital stays, a higher number of comorbid conditions, and multidrug-resistant cases.


Conclusion: The treatment cost of tuberculosis is considerably high, associated factors included length of stay, number of comorbid conditions, and type of Tuberculosis

Article Details

Keywords

treatment cost, Tuberculosis, associated factors

References

[1] World Health Organization (2023), Global Tuberculosis Report 2023.
[2] Winston C. A. et al. (2023), "Estimated Costs of 4-Month Pulmonary Tuberculosis Treatment Regimen, United States", Emerging Infectious Diseases. 29 (10), pp. 2102-2104.
[3] Hoàng Đình Tiếng et al. (2024), "Chi phí y tế trong điều trị bệnh Lao phổi nội trú có bảo hiểm y tế: nghiên cứu cắt ngang tại bệnh viện phổi vĩnh long năm 2023", Tạp Chí Y Học Việt Nam. 538 (2).
[4] Nhung N. V. et al. (2018), "Measuring catastrophic costs due to tuberculosis in Viet Nam", Int J Tuberc Lung Dis. 22 (9), pp. 983-990.
[5] Akalu T. Y. et al. (2023), "Economic burden of multidrug-resistant tuberculosis on patients and households: a global systematic review and meta-analysis", Scientific Reports. 13 (1), pp. 22361.
[6] Li Q. et al. (2024), "Prevalence and epidemic pattern of ecdemic multidrug-resistant tuberculosis during 2012-2022 in Hangzhou, China: implication for public health strategies", BMC Public Health. 24 (1), pp. 2859.